We deliver the research, analysis and integration of complex information and information gaps, in actionable form so that you can move ahead. Let us help you better understand the reimbursement environment for your product and its competitors, so you can capitalize on strengths of yours and neutralize the competition.
Click on the Analysis Services below to learn more.
MEDICAL DEVICE REIMBURSEMENT
A competitive analysis brings everything into question.
- Is medical device reimbursement a competitive advantage, a disadvantage, or a neutral factor in this marketplace?
- What is the status of coding, coverage, and payment for competitive products?
- What kind of medical device reimbursement program do your competitors have in place?
Understanding your competition through competitive analysis is one of the main ways to stay ahead of the game. We provide you with your competition’s medical device reimbursement profile which not only keeps you informed but also allows you to understand what you are up against. RPI is always working to push you ahead of your competition.
- Prospective investors want hard numbers: Potential market size; current treatment strengths, weaknesses and inefficiencies; defensible pricing strategies.
- Facilities want to know why they should invest: Why devote capital and equipment and provide healthcare professional training when their facilities are already skilled at performing the current gold standard procedures?
Data Analysis of Disease Demographics
RPI has the tools and expertise to identify quality disease demographic data sources, mine that data, and then analyze it. The data are the results reported by medical providers and can help our clients target their accessible, regional, and national markets more effectively. This, in turn, allows your investments to create larger returns. RPI can help figure out where the best placement for your medical device is through data analysis of disease demographics.
The Value of Economic Analysis
While many new products enable improved outcomes and reduced costs, both the data and its presentation are subject to comparative effectiveness methodology in order to be credible.
Determining the dominate payers for specific disease states is important to medical device manufacturers. As the following pie charts demonstrate, different payer types are associated with breast and prostate cancer.
To give an example, within the realm of breast and prostate cancer, the payer-mix is very different.
Within the breast cancer market, private payers are 49% of the payer mix compared to the prostate cancer market where only 15% of the payers are private. Medicare actually leads the prostate payer market with 64%.
Knowing which types of payers from the payer-mix will dominate your product’s market enables you to choose education and advocacy methods targeted specifically to them. The right combination of clinical, regulatory, and contract expertise will vary by payer. At RPI, we equip you with the right blend of expertise for the payer-mix within your marketplace.
PAYER PROFILING AND SEGMENTATION
Healthcare Economics – Comparative Effectiveness Research
There are multiple aspects about the payer market that need to be understood to successfully launch and sustain a place within the medical market.
- How do you target a payer?
- What are the details that you should know?
You need to know the payers who are already receptive to your technology and those who need further payer education. RPI will profile and segment the relevant payers for you by examining their medical policies which are applicable to your product. With this knowledge, you can target appropriate actions for each payer segment and, if needed, identify additional data requirements for building payer acceptance.
Establishing the right price for your medical device requires three things: extensive knowledge of documented and expected clinical outcomes, documented and expected provider costs, and competitive data. The most credible data for medical device pricing generally comes from the published medical literature which can sometimes be spotty. We build our medical device pricing models on the best available documented data and probable results for your product, yet we also allow you to alter the variables in the event of new information. Multiple medical device pricing scenarios and what if exercises maximize your confidence in medical device pricing decisions.
The way in which the reimbursement value of your medical device is determined, proven, and communicated is essential to generating success in the marketplace. The results of a reimbursement value analysis will have serious implications on your medical device’s clinical and market development.
There are three main aspects to reimbursement value analysis:
- Setting The Right Price
- Conducting The Right Studies
- Sending The Right Message
The medical device’s price is important to your customers and plays a significant role in medical device reimbursement.
Its important to send the correct message to the appropriate target market and at RPI, we acknowledge that this is an extensive and time-consuming undertaking. We can help you articulate and document your value effectively.